Cargando…

Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary

BACKGROUND: Sarcomas are rare and heterogeneous tumours of mesenchymal origin, with over 100 histological subtypes. Paraneoplastic dermatomyositis has rarely been described in sarcoma. This is the first documented case of paraneoplastic dermatomyositis in a patient with metastatic leiomyosarcoma. CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Merry, Eve, Smrke, Alannah, Halai, Kapil, Patel, Gulam, Thway, Khin, Jones, Robin L., Benson, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448307/
https://www.ncbi.nlm.nih.gov/pubmed/32864095
http://dx.doi.org/10.1186/s13569-020-00140-w
_version_ 1783574473699491840
author Merry, Eve
Smrke, Alannah
Halai, Kapil
Patel, Gulam
Thway, Khin
Jones, Robin L.
Benson, Charlotte
author_facet Merry, Eve
Smrke, Alannah
Halai, Kapil
Patel, Gulam
Thway, Khin
Jones, Robin L.
Benson, Charlotte
author_sort Merry, Eve
collection PubMed
description BACKGROUND: Sarcomas are rare and heterogeneous tumours of mesenchymal origin, with over 100 histological subtypes. Paraneoplastic dermatomyositis has rarely been described in sarcoma. This is the first documented case of paraneoplastic dermatomyositis in a patient with metastatic leiomyosarcoma. CASE PRESENTATION: A 43-year-old female diagnosed with metastatic leiomyosarcoma of unknown primary presented with a mild rash in sun-exposed areas of her face and upper chest, with no other neuromuscular symptoms. This rash resolved with systemic treatment with doxorubicin for metastatic leiomyosarcoma. Imaging assessment confirmed overall stable disease after chemotherapy completion. She presented acutely 2 months later with new onset rash in a shawl-like distribution, periorbital oedema and proximal muscle weakness. Based on the characteristic cutaneous signs and symmetrical proximal muscle weakness, abnormal electromyography and raised skeletal muscle enzymes with a positive anti-transcription intermediary factor-1 gamma antibody result, a diagnosis of paraneoplastic dermatomyositis was made. Re-evaluation of her metastatic leiomyosarcoma revealed disease progression. Second-line chemotherapy was commenced once the dermatomyositis was controlled on steroid therapy. Systemic anti-cancer therapy was again associated with mild improvement in dermatomyositis symptoms. DISCUSSION: Paraneoplastic dermatomyositis heralded disease progression after first-line chemotherapy; however, in hindsight, subtle cutaneous features were present at sarcoma diagnosis. The temporal relationship between paraneoplastic dermatomyositis and metastatic leiomyosarcoma is key in this case, as fluctuations in dermatomyositis severity correlated with growth of metastatic disease. Understanding this relationship may provide clues for tumour progression and prompt timely initiation of anti-cancer therapy. It is important to recognise that in addition to the more common cancers associated with paraneoplastic dermatomyositis, it can also occur in rarer tumours such as leiomyosarcoma.
format Online
Article
Text
id pubmed-7448307
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74483072020-08-27 Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary Merry, Eve Smrke, Alannah Halai, Kapil Patel, Gulam Thway, Khin Jones, Robin L. Benson, Charlotte Clin Sarcoma Res Case Report BACKGROUND: Sarcomas are rare and heterogeneous tumours of mesenchymal origin, with over 100 histological subtypes. Paraneoplastic dermatomyositis has rarely been described in sarcoma. This is the first documented case of paraneoplastic dermatomyositis in a patient with metastatic leiomyosarcoma. CASE PRESENTATION: A 43-year-old female diagnosed with metastatic leiomyosarcoma of unknown primary presented with a mild rash in sun-exposed areas of her face and upper chest, with no other neuromuscular symptoms. This rash resolved with systemic treatment with doxorubicin for metastatic leiomyosarcoma. Imaging assessment confirmed overall stable disease after chemotherapy completion. She presented acutely 2 months later with new onset rash in a shawl-like distribution, periorbital oedema and proximal muscle weakness. Based on the characteristic cutaneous signs and symmetrical proximal muscle weakness, abnormal electromyography and raised skeletal muscle enzymes with a positive anti-transcription intermediary factor-1 gamma antibody result, a diagnosis of paraneoplastic dermatomyositis was made. Re-evaluation of her metastatic leiomyosarcoma revealed disease progression. Second-line chemotherapy was commenced once the dermatomyositis was controlled on steroid therapy. Systemic anti-cancer therapy was again associated with mild improvement in dermatomyositis symptoms. DISCUSSION: Paraneoplastic dermatomyositis heralded disease progression after first-line chemotherapy; however, in hindsight, subtle cutaneous features were present at sarcoma diagnosis. The temporal relationship between paraneoplastic dermatomyositis and metastatic leiomyosarcoma is key in this case, as fluctuations in dermatomyositis severity correlated with growth of metastatic disease. Understanding this relationship may provide clues for tumour progression and prompt timely initiation of anti-cancer therapy. It is important to recognise that in addition to the more common cancers associated with paraneoplastic dermatomyositis, it can also occur in rarer tumours such as leiomyosarcoma. BioMed Central 2020-08-25 /pmc/articles/PMC7448307/ /pubmed/32864095 http://dx.doi.org/10.1186/s13569-020-00140-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Merry, Eve
Smrke, Alannah
Halai, Kapil
Patel, Gulam
Thway, Khin
Jones, Robin L.
Benson, Charlotte
Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
title Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
title_full Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
title_fullStr Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
title_full_unstemmed Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
title_short Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
title_sort paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448307/
https://www.ncbi.nlm.nih.gov/pubmed/32864095
http://dx.doi.org/10.1186/s13569-020-00140-w
work_keys_str_mv AT merryeve paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary
AT smrkealannah paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary
AT halaikapil paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary
AT patelgulam paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary
AT thwaykhin paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary
AT jonesrobinl paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary
AT bensoncharlotte paraneoplasticdermatomyositisassociatedwithmetastaticleiomyosarcomaofunknownprimary